Cargando…

Ezh2, a novel target in detection and therapy of breast cancer

Detalles Bibliográficos
Autores principales:	Pourakbar, Sarah, Pluard, Timothy J, Accurso, Anthony D, Farassati, Faris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449122/ https://www.ncbi.nlm.nih.gov/pubmed/28579806 http://dx.doi.org/10.2147/OTT.S138777

Ejemplares similares

Cancer stem cells, the ultimate targets in cancer therapy
por: Shabbir, Ahmed, et al.
Publicado: (2018)

Targeting Cancer Stem Cells by Oncolytic Viruses and Nano-Mediated Delivery
por: Hosseini, Mahsa, et al.
Publicado: (2020)

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran
por: Boostani, Farnaz, et al.
Publicado: (2018)

Editorial announcing PubMed indexing of Oncolytic Virotherapy
por: Farassati, Faris
Publicado: (2017)

The role of KPNβ(1) in neuro-oncology
por: Lilley, Megan, et al.
Publicado: (2017)

Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)

EZH2: novel therapeutic target for human cancer
por: Li, Long-Yuan
Publicado: (2014)

EZH2: a novel target for cancer treatment
por: Duan, Ran, et al.
Publicado: (2020)

Targeting EZH2 for Cancer Therapy: Progress and Perspective
por: Li, Chi Han, et al.
Publicado: (2015)

Unveiling the non-canonical functions of EZH2 in prostate cancer
por: Yi, Yang, et al.
Publicado: (2023)

Ral signaling pathway in health and cancer
por: Moghadam, Adel Rezaei, et al.
Publicado: (2017)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

Understanding Breast-Cancer-Associated Fibroblasts and Their Epigenetic Activation to Unveil Novel Targets for Breast Cancer Therapy
por: Ahmad, Aamir
Publicado: (2023)

EZH2 as a Potential Target for NAFLD Therapy
por: Lim, Hyun Jung, et al.
Publicado: (2020)

A novel KRAS gene mutation report in sporadic colorectal cancer, from Northwest of Iran
por: Dolatkhah, Roya, et al.
Publicado: (2017)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
por: Wang, Xiang, et al.
Publicado: (2019)

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
por: Bao, Yi, et al.
Publicado: (2020)

Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells
por: Wang, Kun, et al.
Publicado: (2012)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Innovations in Personalized and Targeted Therapies for Breast Cancer
por: Harris, Eleanor E. R., et al.
Publicado: (2018)

Ras Signalling Pathway: A Gateway for HSV-1 Infection
por: Farassati, Faris, et al.
Publicado: (2003)

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
por: Li, Zhongwu, et al.
Publicado: (2013)

EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
por: Wang, Bohan, et al.
Publicado: (2023)

Targeted Therapies; Who Detects the Target?
por: Meijer, G. A., et al.
Publicado: (2005)

EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015)

RAGE: A novel target for breast cancer growth and metastasis
por: Nasser, Mohd W., et al.
Publicado: (2016)

MicroRNAs: Emerging Novel Targets of Cancer Therapies
por: Yang, Chengfeng, et al.
Publicado: (2015)

Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
por: Hirukawa, Alison, et al.
Publicado: (2018)

Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
por: Ding, Shu, et al.
Publicado: (2022)

Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1
por: Pan, Weihong, et al.
Publicado: (2009)

Clinical Value of EZH2 in Hepatocellular Carcinoma and Its Potential for Target Therapy
por: Bae, An-Na, et al.
Publicado: (2022)

Non-canonical functions of EZH2 in cancer
por: Zimmerman, Sarah M., et al.
Publicado: (2023)

NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
por: Pappas, Kyrie, et al.
Publicado: (2021)

miR-92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2
por: Liu, Fei, et al.
Publicado: (2018)

ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022)

EZH2 expression in invasive lobular carcinoma of the breast
por: Roh, SiGyun, et al.
Publicado: (2013)

Targeting LSD2 in breast cancer
por: Huang, Yi, et al.
Publicado: (2018)

Targeting EZH2 as a novel therapeutic strategy for sorafenib‐resistant thyroid carcinoma
por: Wang, Zhengshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dmf8dqqhivc47p3as19n8hh9p1